State of the art in magnetic resonance imaging of hepatocellular carcinoma

State of the art in magnetic resonance imaging of hepatocellular carcinoma

Liver cancer is the sixth most common cancer worldwide and the second leading cause of cancer mortality. Chronic liver disease caused by viral infection, alcohol abuse, or other factors can lead to cirrhosis. Cirrhosis is the most important clinical risk factor for hepatocellular carcinoma (HCC) whe...

Full description

Bibliographic Details
Main Authors:	Horvat Natally, Monti Serena, Oliveira Brunna Clemente, Rocha Camila Carlos Tavares, Giancipoli Romina Grazia, Mannelli Lorenzo
Format:	Article
Language:	English
Published:	Sciendo 2018-11-01
Series:	Radiology and Oncology
Subjects:	hepatocellular carcinoma hepatic nodule liver cirrhosis magnetic resonance imaging
Online Access:	https://doi.org/10.2478/raon-2018-0044

Similar Items

Reply to comments on “State of the art in magnetic resonance imaging of hepatocellular carcinoma”: the role of DWI
by: Horvat Natally, et al.
Published: (2019-07-01)

An unfortunate failure: multifocal hepatocellular carcinoma in a non-cirrhotic patient with chronic hepatitis C treated with ledipasvir/sofosbuvir
by: Megan Sue Soliman, et al.
Published: (2018-05-01)

Substernal Mass: A Rare Presentation of Hepatocellular Carcinoma
by: Kevin Yuqi Wang, et al.
Published: (2019-11-01)

Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
by: Chih-Lin Lin, et al.
Published: (2023-07-01)

Clinical Value of Contrast-enhanced Ultrasound in Differential Diagnosis of Early Hepatocellular Carcinoma and Dysplastic Nodules
by: Jianmin Ding, MD, Yan Zhou, MD, Yandong Wang, MD, Hongyu Zhou, MD, Xiang Jing, MD
Published: (2017-03-01)

Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma
by: Sara Naimimohasses, et al.
Published: (2017-12-01)

Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
by: Ruipeng Zheng, et al.
Published: (2020-06-01)

Hepatocellular carcinoma: Epidemiological profile from a cohort of federal employees in Mexico
by: Laura Ladrón de Guevara,, et al.
Published: (2009-07-01)

Hepatocellular carcinoma in patients with autoimmune liver diseases: Two case reports and literature review
by: Judith Meza-Junco;, et al.
Published: (2007-04-01)

Hepatitis D Virus and Hepatocellular Carcinoma
by: Patrizia Farci, et al.
Published: (2021-05-01)

Prognostic value of serum autotaxin in liver cirrhosis and prediction of hepatocellular carcinoma
by: Nagwa Ramadan Ahmed, et al.
Published: (2019-01-01)

Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
by: Khaled Mohieldeen, et al.
Published: (2021-09-01)

Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis
by: Liangliang Xu, et al.
Published: (2022-09-01)

Epidemiología molecular del virus de la hepatitis C
by: Karina Salvatierra

Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
by: Chen B, et al.
Published: (2022-12-01)

A Case of Composite Hepatocellular Carcinoma and Neuroendocrine Carcinoma in a Patient with Liver Cirrhosis Caused by Chronic Hepatitis B
by: Eun Young Yun, et al.
Published: (2016-08-01)

Locoregional treatment approaches for hepatocellular carcinoma – a case report
by: Helga Sertić-Milić, et al.
Published: (2022-01-01)

The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma
by: Wei Zhang, et al.
Published: (2021-09-01)

Metabolomics and network analysis uncovered profound inflammation-associated alterations in hepatitis B virus-related cirrhosis patients with early hepatocellular carcinoma
by: Zhiyong Du, et al.
Published: (2023-05-01)

Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
by: Ze-Hong Huang, et al.
Published: (2022-03-01)

Assessment of Plasma Vitronectin as Diagnostic and Prognostic Marker of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Cirrhosis
by: Salem Youssef Mohamed, et al.
Published: (2022-01-01)

Subtle Hepatocellular Carcinoma: A Persisting Role for Alpha-Fetoprotein Monitoring in High-Risk Patients with Cirrhosis
by: Barry Schlansky, et al.
Published: (2011-10-01)

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
by: Won Sohn, et al.
Published: (2023-01-01)

Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
by: Germana Castelli, et al.
Published: (2017-09-01)

Association of Polymorphisms in the Glutathione S-Transferase Theta-1 Gene with Cirrhosis and Hepatocellular Carcinoma in Brazilian Patients with Chronic Hepatitis C
by: Oscar C. Araujo, et al.
Published: (2021-07-01)

Raised Alpha-Fetoprotein Level and its Association with Hepatocellular Carcinoma
by: Madiha Hashmi, et al.
Published: (2023-10-01)

Hepatitis B infection: review article
by: Jafar Mohammadshahi, et al.
Published: (2018-12-01)

Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis
by: Yang An, et al.
Published: (2021-10-01)

A case of hepatic pseudolymphoma in a patient with primary biliary cirrhosis
by: Masashi Inoue, et al.
Published: (2019-10-01)

Hepatocellular carcinoma in hispanics
by: Nahum Méndez-Sánchez, et al.
Published: (2007-10-01)

Incidence of Hepatocellular Carcinoma in Patients with Thalassemia Who Had Hepatitis C
by: Shahla Ansari, et al.
Published: (2013-06-01)

Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
by: Xiaofei Li, et al.
Published: (2020-04-01)

Diagnosis with Echocardiography for Rare Cases of Anomalous Left Main Coronary Artery: Two Case Reports and Important Lessons Learned
by: Xianghong Luo, MD, Qian Zhang, MD, Qing Yan, MD, Jufang Wang, MD, Qingqing Dong, MD, Zhaojun Li, MD
Published: (2017-03-01)

Synchronous Hepatocellular Carcinoma and Cholangiocarcinoma in a Patient Transplanted for Cryptogenic Cirrhosis
by: B Geramizadeh, et al.
Published: (2014-07-01)

Profile of hepatocellular carcinoma in the Republic of Moldova: first-hand information on the presentation, distribution and etiologies
by: Turcanu Adela, et al.
Published: (2019-03-01)

Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals
by: Ke Shi, et al.
Published: (2023-02-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

Outcomes and Predictors of 30-Day Readmission in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization between 2016 and 2018
by: Ifrah Fatima, et al.
Published: (2024-01-01)

Characteristics and prognosis of hepatocellular carcinoma in multi-transfused patients with thalassemia major. Experience of a single tertiary center.
by: Nikolaos Papadopoulos, et al.
Published: (2020-02-01)